Clinical Trial Update: Neoadjuvant Therapy With Conservative Surgery vs. Up-front Conservative Surgery for BRAF V600E-Mutated Ameloblastoma [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating neoadjuvant therapy followed by conservative surgery versus upfront conservative surgery for patients with BRAF V600E-m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ameloblastoma

Snippet

Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Conditions: Ameloblastoma | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING